Administration of recombinant thrombomodulin before progression of disease causing disseminated intravascular coagulation might be better compared with administration after progression of disease

Table 3 Multivariate logistic regression analysis for outcome

	Reference	Adjusted odds ratio	95% confidence interval	pvalue
Gender	Female	3.39	1.19–9.64	0.022
APACHEII at start of rTM	-	1.18	1.09–1.29	<0.001
rTM 1 day	0 days	1.95	0.57–6.62	0.29
rTM 2 days	0 days	3.36	1.03–10.92	0.044

Hosmer-Lemeshow test (chi-square = 15.13, degrees of freedom = 8, p = 0.057).
C-statistics = 0.82.
APACHEII Acute Physiology and Chronic Health Evaluation II, rTM recombinant thrombomodulin. rTM x day Duration from the onset of disease to rTM administration was x day, 2- days more than 2 days.

ISSN: 2052-0492